Pledge Therapeutics Email Format

Biotechnology ResearchMassachusetts, United States11-50 Employees

Pledge Therapeutics operates within the biotechnology research sector, focusing on translating clinical and disease insights into target identification and the development of novel drug molecules. The company emphasizes integrating structural and biophysical knowledge of disease targets to accelerate drug discovery and progression from early hits to preclinical candidates. Based in Canton, Massachusetts, the organization describes its work as advancing understanding of disease biology to support the creation of new therapeutic options.

Its target market comprises partners and collaborators in need of early-stage drug discovery and target development capabilities. By converting clinical observations into actionable targets and rapid candidate development, Pledge Therapeutics positions itself as a contributor to the early-drug development landscape, bridging scientific insight with practical molecule development in the biotechnology industry.

Sign up for free to view info

Company overview Employee directory